市場調査レポート
商品コード
1559459
膝関節再建デバイス - 市場考察、競合情勢、市場予測(2030年)Knee Reconstruction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
膝関節再建デバイス - 市場考察、競合情勢、市場予測(2030年) |
出版日: 2024年09月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の膝関節再建/置換デバイスの市場規模は、2023年に75億4,000万米ドルであり、2030年までに97億8,000万米ドルに達すると予測され、2024年~2030年の予測期間にCAGRで4.52%の成長が見込まれます。市場は、変形性関節症や関節リウマチのような変性骨疾患の流行、製品開発/イノベーション活動の増加などの主な要因が市場成長に寄与し、2024年~2030年の予測期間に大きな成長を示しています。
膝関節再建/置換デバイスの市場力学
世界保健機関(WHO)(2023年)によると、世界全体で3億4,400万人が変形性膝関節症に罹患しています。このうち、変形性関節症患者の73%は55歳超で、60%は女性です。変形性関節症は、膝関節の軟骨の破壊を特徴とする退行性関節疾患であり、痛み、こわばり、可動域の減少をもたらします。この疾患はしばしば関節に重大な損傷をもたらし、機能回復と症状緩和に人工膝関節置換術が必要になることがあります。
同じ資料によると、1,300万人が関節リウマチを患っています。関節リウマチになると、関節の内壁が炎症を起こして侵食され、軟骨や骨の破壊が進行します。人工膝関節置換術(全置換術または部分置換術)は、損傷した関節面を人工装具で置換し、機能を回復させて痛みを和らげるために行われます。
さらに2023年10月、Indian Spinal Injuries Centre(ISIC)は、ロボットによる人工膝関節置換術を専門とする新部門を導入し、インドの整形外科医療に大きな進歩をもたらしました。同センターは、ワルシャワに本社を置くZimmer BiometのRosa Robotics Knee Systemを展開しました。
規制当局による承認や上市などの製品開発活動の活発化も、膝関節再建/置換デバイス市場の成長に直面する見込みです。例えば2024年6月、グジャラート州を拠点とする医療デバイスメーカーMerilは、自社開発の手術用ロボット技術MISSOを発表しました。この革新的なシステムは、人工膝関節置換術の際に医師をリアルタイムで支援するために設計されたもので、手術にかかるコストを最大66%削減できると予測されています。
したがって、2024年~2030年の予測期間に上記のような要因が相互に作用して、膝関節再建/置換デバイス市場を牽引すると予測されます。
しかし、インプラントに伴う神経や血管の損傷、出血、硬さ、神経損傷によるしびれ、脱力感、痛みなどが、膝関節再建/置換デバイス市場の成長を抑制する可能性があります。
膝関節再建/置換デバイス市場のセグメント分析
膝関節再建/置換デバイス市場の製品タイプセグメントでは、人工膝関節全置換術システムのカテゴリが2023年に最大の市場収益シェアを占めると予測されています。このカテゴリの急成長は、重度の膝関節炎や関節障害の治療に使用される先進のインプラントによるものと考えられます。人工膝関節全置換術は、コバルトクロム合金や超高分子量ポリエチレンのような耐久性のある材料で作られた、大腿骨、脛骨、膝蓋骨の3つの主要コンポーネントで構成されています。
最新の人工膝関節全置換術システムは、カスタマイズ可能なサイズ設定、モジュール設計、コンピューター支援ナビゲーションやロボット支援などの先進技術を特徴としており、正確なインプラント埋入や治療成績の向上を保証します。これらの技術革新は、関節機能を高め、痛みを軽減し、回復を早めることで、患者のQOLを大幅に向上させます。
さらに、製品開発活動の高まりが、これらの市場を拡大しています。例えば2024年5月、手術技術の革新で産業をリードするOrthAlign, Inc.は、同社の主力製品である「Lantern」を、日本で人工膝関節全置換術向けに発売することを発表しました。この発売を支えたのは、2013年から市場でOrthAlignの代理店を務め、6万8,000件を超えるOrthAlign症例をサポートしてきた長年の商業パートナーです。
したがって、幅広い機能と用途を持つ人工膝関節全置換術システムカテゴリの強固な製品ポートフォリオのプレゼンスは、かなりの成長を示し、結果として2024年~2030年の予測期間に膝関節再建/置換デバイス市場全体の成長に寄与する見込みです。
当レポートでは、世界の膝関節再建デバイス市場について調査分析し、各地域の市場規模と予測、過去3年間の製品/技術開発、各セグメントの業績と見通しなどの情報を提供しています。
Knee Reconstruction/Replacement Devices Market by Product Type (Total Knee Arthroplasty Systems, Partial Knee Arthroplasty Systems, and Knee Revision Systems), Implant Type (Fixed Tibial Bearing Implants, Mobile Tibial Bearing Implants, and Medial Pivot Implants), Fixation (Cemented and Cementless), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing number of bone-related disorders and the rising product developmental activities across the globe
The knee reconstruction/replacement devices market was valued at USD 7.54 billion in 2023, growing at a CAGR of 4.52% during the forecast period from 2024 to 2030 to reach USD 9.78 billion by 2030. The knee reconstruction/replacement devices market is experiencing significant growth owing to the widespread instances of degenerative bone conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, among others that are acting as key factors, thus contributing to the market growth of the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.
Knee Reconstruction/Replacement Devices Market Dynamics:
According to the World Health Organization (2023), 344 million individuals are affected by osteoarthritis globally. Among this population, 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage in the knee joint, leading to pain, stiffness, and reduced range of motion. This condition often results in significant joint damage that may necessitate knee replacement surgery to restore function and alleviate symptoms.
As per the same source, 13 million people are living with rheumatoid arthritis. This causes the joint lining to become inflamed and eroded, leading to progressive destruction of the cartilage and bone. Knee replacement surgery, either total or partial, is used to replace the damaged joint surfaces with prosthetic components, restoring function and alleviating pain.
Moreover, in October 2023, The Indian Spinal Injuries Centre (ISIC) introduced a new department dedicated to robotic knee replacement surgery, marking a significant advancement in orthopedic care in India. The center deployed the Rosa Robotics Knee System from Zimmer Biomet, based in Warsaw.
Increased product developmental activities such as approvals by the regulatory bodies and launches are also slated to witness the market growth of knee reconstruction/replacement devices. For instance, in June 2024, Meril, a Gujarat-based medical devices company, introduced its indigenously developed surgical robotic technology, MISSO. This innovative system was designed to assist doctors during knee replacement surgeries in real-time and was expected to reduce the cost of these procedures by up to 66 percent.
Hence, the interplay of all the above mentioned factors are expected to drive the market for knee reconstruction/replacement devices during the given forecast period from 2024 to 2030.
However, nerve and blood vessel injury, bleeding, and stiffness associated with implants, nerve damage can cause numbness, weakness and pain and others may restrain the growth of the Knee Reconstruction/Replacement devices market.
Knee Reconstruction/Replacement Devices Market Segment Analysis:
Knee Reconstruction/Replacement Devices Market by Product Type (Total Knee Arthroplasty Systems, Partial Knee Arthroplasty Systems, and Knee Revision Systems), Implant Type (Fixed Tibial Bearing Implants, Mobile Tibial Bearing Implants, and Medial Pivot Implants), Fixation (Cemented and Cementless), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the knee reconstruction/replacement devices market, the total knee arthroplasty systems category is predicted to account for the largest market revenue share in 2023. The rapid growth of this category can be attributed due to advanced implants used to treat severe knee arthritis or joint disorders. They consist of three main components-femoral, tibial, and patellar parts, made from durable materials like cobalt-chromium alloys and ultra-high molecular weight polyethylene.
Modern total knee arthroplasty systems feature customizable sizing, modular designs, and advanced technologies such as computer-assisted navigation and robotic assistance to ensure precise implant placement and improved outcomes. These innovations enhance joint function, reduce pain, and accelerate recovery, significantly improving patients' quality of life.
Additionally, the rising product developmental activities increases the market for these. For example, in May 2024, OrthAlign, Inc., a leading innovator in surgical technology, announced the launch of its flagship product, Lantern, in Japan for total knee arthroplasty. The launch was supported by its longstanding commercial partner, who had represented OrthAlign in the market since 2013 and had supported over 68,000 OrthAlign cases.
Therefore, the presence of a robust product portfolio for the total knee arthroplasty systems category with a wide range of features and applications is expected to witness considerable growth, eventually contributing to the growth of the overall knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall knee reconstruction/replacement devices market:
Among all the regions, North America is expected to amass the largest share of the knee reconstruction/replacement devices market. This can be ascribed to the high incidence of knee-related conditions such as arthritis and gout, advancements in surgical technology and robotic navigation systems, as well as the presence of leading market players driving innovation in knee reconstruction and replacement. Collectively, these factors are expected to drive the demand for knee reconstruction and replacement devices throughout the forecast period from 2024 to 2030.
According data from the American Academy of Orthopaedic Surgeons in 2024 stated that over 700,000 total knee replacement surgeries are performed each year in the US. In addition to this, recent updates provided by the Arthritis Society Canada (2022), stated that 1 million Canadians were affected by gout, which is the most common form of inflammatory arthritis. Gout predominantly impacts males more than females, with approximately 4% of men and 1% of women affected. Among the various joints that can be affected, the knee joint is the most commonly involved. Knee replacement and reconstruction surgeries are crucial for managing severe knee pain and dysfunction caused by conditions like arthritis and gout. These procedures are especially important for patients whose knee joints are significantly affected, offering relief from pain and improved mobility by replacing damaged joints with artificial ones.
The product developmental activities by regulatory bodies in the region also push forward the revenue shares of knee reconstruction devices. For example in July 2024, Globus Medical, Inc. announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ExcelsiusFlex(TM) with Total Knee Arthroplasty (TKA) application. This new robotic navigation platform was added to the already best-in-class Excelsius(TM) ecosystem, designed to provide surgeons with enhanced control, resection accuracy, and procedural flexibility in Total Knee Arthroplasty. Additionally, the ACTIFY(TM) 3D Total Knee System, the latest in implant technology designed to pair with ExcelsiusFlex(TM), also received 510(k) clearance.
Moreover, the presence of key players such as Zimmer Biomet, Stryker, Johnson & Johnson Services, Inc, Exactech, Inc., and others in the region is also a driving factor for the knee reconstruction/replacement devices market as they hold significant revenue shares.
Thus, all the factors mentioned above promote a conducive environment for the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.
Knee Reconstruction/Replacement Devices Market key players:
Some of the key market players operating in the Knee Reconstruction/Replacement Devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exatech Inc, Johnson & Johnson Services, Inc, Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO Global, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, and others.
Recent Developmental Activities in the Knee Reconstruction/Replacement Devices Market:
Key Takeaways from the Knee Reconstruction/Replacement Devices Market Report Study
Target audience who can be benefited from this Knee Reconstruction/Replacement Devices Market Report Study
Frequently Asked Questions for the Knee Reconstruction/Replacement Devices Market:
The knee reconstruction/replacement devices are devices designed to replace cartilage and bone which is damaged from musculoskeletal disease or aging. There are various replacement devices such as total knee arthroplasty systems, and partial knee arthroplasty systems, among others.
The knee reconstruction/replacement devices market was valued at USD 7.54 billion in 2023, growing at a CAGR of 4.52% during the forecast period from 2024 to 2030 to reach USD 9.78 billion by 2030.
The knee reconstruction/replacement devices market is experiencing significant growth owing to the widespread instances of degenerative conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, among others that are acting as key factors, contributing to the market growth of the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.
Some of the key market players operating in the Knee Reconstruction/Replacement devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exatech Inc., Johnson & Johnson Services, Inc., Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO Global, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, and others.
Among all the regions, North America is estimated to hold a significant revenue share in the knee reconstruction/replacement devices market. This can be ascribed to the high incidence of knee-related conditions such as arthritis and gout, advancements in surgical technology and robotic navigation systems, as well as the presence of leading market players driving innovation in knee reconstruction and replacement. Collectively, these factors are expected to drive the demand for knee reconstruction and replacement devices throughout the forecast period from 2024 to 2030.